Drug Type Unknown |
Synonyms- |
Target |
Action inhibitors, blockers |
Mechanism GLUT1 inhibitors(Glucose transporter 1 inhibitors), GLUT2 blockers(solute carrier family 2 member 2 blockers), SLC2A3 blockers(solute carrier family 2 member 3 blockers) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | Austria | 19 Sep 2019 | |
Neoplasms | Preclinical | Germany | 19 Sep 2019 | |
Neoplasms | Preclinical | Germany | 19 Sep 2019 |